FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024531812> ?p ?o ?g. }

• W2024531812 endingPage "3938" @default.
• W2024531812 startingPage "3929" @default.
• W2024531812 abstract "Phenoxodiol (PXD) is a synthetic analogue of the plant isoflavone genistein with improved anticancer efficacy. Various properties and mechanisms of action have been attributed to the drug, the most important being its ability to sensitize resistant tumour cells to chemotherapy, which led to its fast track FDA approval for phase II/III clinical trials. In this study, we examined the effects of PXD on human peripheral blood mononuclear cells (PBMC) and its potential role in regulating immune responses. We show that PXD, at concentrations ≥1 μg/ml (4 μM), inhibited proliferation and reduced the viability of healthy donor-derived PBMC. In contrast, lower PXD concentrations (0.05–0.5 μg/ml) augmented, upon 3-day incubation, PBMC cytotoxicity. Experiments with purified CD56+ lymphocytes revealed that PXD enhanced the lytic function of natural killer (NK) cells by directly stimulating this lymphocytic subpopulation. Furthermore, in an in vivo colon cancer model, Balb/C mice administered low-dose PXD, exhibited significantly reduced tumour growth rates and prolonged survival (in 40% of the animals). Ex vivo results showed that PXD stimulated both NK and tumour-specific cell lytic activity. We conclude that PXD, when administered at low concentrations, can act as an immunomodulator, enhancing impaired immune responses, often seen in cancer-bearing individuals." @default.
• W2024531812 created "2016-06-24" @default.
• W2024531812 creator A5011983627 @default.
• W2024531812 creator A5016546590 @default.
• W2024531812 creator A5030747893 @default.
• W2024531812 creator A5033573338 @default.
• W2024531812 creator A5041597500 @default.
• W2024531812 creator A5044816785 @default.
• W2024531812 creator A5045869380 @default.
• W2024531812 creator A5062363261 @default.
• W2024531812 creator A5067226239 @default.
• W2024531812 creator A5080777038 @default.
• W2024531812 date "2009-02-11" @default.
• W2024531812 modified "2023-09-29" @default.
• W2024531812 title "Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo" @default.
• W2024531812 cites W1524049020 @default.
• W2024531812 cites W1551811517 @default.
• W2024531812 cites W1937331953 @default.
• W2024531812 cites W1983539658 @default.
• W2024531812 cites W1994959945 @default.
• W2024531812 cites W2000678775 @default.
• W2024531812 cites W2007065511 @default.
• W2024531812 cites W2014655291 @default.
• W2024531812 cites W2017627233 @default.
• W2024531812 cites W2034003071 @default.
• W2024531812 cites W2040777081 @default.
• W2024531812 cites W2046713027 @default.
• W2024531812 cites W2046746362 @default.
• W2024531812 cites W2083115741 @default.
• W2024531812 cites W2090186432 @default.
• W2024531812 cites W2109792915 @default.
• W2024531812 cites W2111901836 @default.
• W2024531812 cites W2137523922 @default.
• W2024531812 cites W2142880518 @default.
• W2024531812 cites W2148220584 @default.
• W2024531812 cites W2152522041 @default.
• W2024531812 cites W2157103515 @default.
• W2024531812 cites W2262639847 @default.
• W2024531812 cites W2402738411 @default.
• W2024531812 doi "https://doi.org/10.1111/j.1582-4934.2009.00695.x" @default.
• W2024531812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4516540" @default.
• W2024531812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19220577" @default.
• W2024531812 hasPublicationYear "2009" @default.
• W2024531812 type Work @default.
• W2024531812 sameAs 2024531812 @default.
• W2024531812 citedByCount "26" @default.
• W2024531812 countsByYear W20245318122012 @default.
• W2024531812 countsByYear W20245318122013 @default.
• W2024531812 countsByYear W20245318122015 @default.
• W2024531812 countsByYear W20245318122017 @default.
• W2024531812 countsByYear W20245318122018 @default.
• W2024531812 countsByYear W20245318122019 @default.
• W2024531812 countsByYear W20245318122020 @default.
• W2024531812 countsByYear W20245318122021 @default.
• W2024531812 countsByYear W20245318122022 @default.
• W2024531812 countsByYear W20245318122023 @default.
• W2024531812 crossrefType "journal-article" @default.
• W2024531812 hasAuthorship W2024531812A5011983627 @default.
• W2024531812 hasAuthorship W2024531812A5016546590 @default.
• W2024531812 hasAuthorship W2024531812A5030747893 @default.
• W2024531812 hasAuthorship W2024531812A5033573338 @default.
• W2024531812 hasAuthorship W2024531812A5041597500 @default.
• W2024531812 hasAuthorship W2024531812A5044816785 @default.
• W2024531812 hasAuthorship W2024531812A5045869380 @default.
• W2024531812 hasAuthorship W2024531812A5062363261 @default.
• W2024531812 hasAuthorship W2024531812A5067226239 @default.
• W2024531812 hasAuthorship W2024531812A5080777038 @default.
• W2024531812 hasBestOaLocation W20245318122 @default.
• W2024531812 hasConcept C109316439 @default.
• W2024531812 hasConcept C137061746 @default.
• W2024531812 hasConcept C150903083 @default.
• W2024531812 hasConcept C185592680 @default.
• W2024531812 hasConcept C202751555 @default.
• W2024531812 hasConcept C203014093 @default.
• W2024531812 hasConcept C207001950 @default.
• W2024531812 hasConcept C502942594 @default.
• W2024531812 hasConcept C55493867 @default.
• W2024531812 hasConcept C86803240 @default.
• W2024531812 hasConcept C8891405 @default.
• W2024531812 hasConcept C98274493 @default.
• W2024531812 hasConceptScore W2024531812C109316439 @default.
• W2024531812 hasConceptScore W2024531812C137061746 @default.
• W2024531812 hasConceptScore W2024531812C150903083 @default.
• W2024531812 hasConceptScore W2024531812C185592680 @default.
• W2024531812 hasConceptScore W2024531812C202751555 @default.
• W2024531812 hasConceptScore W2024531812C203014093 @default.
• W2024531812 hasConceptScore W2024531812C207001950 @default.
• W2024531812 hasConceptScore W2024531812C502942594 @default.
• W2024531812 hasConceptScore W2024531812C55493867 @default.
• W2024531812 hasConceptScore W2024531812C86803240 @default.
• W2024531812 hasConceptScore W2024531812C8891405 @default.
• W2024531812 hasConceptScore W2024531812C98274493 @default.
• W2024531812 hasIssue "9b" @default.
• W2024531812 hasLocation W20245318121 @default.
• W2024531812 hasLocation W20245318122 @default.
• W2024531812 hasLocation W20245318123 @default.
• W2024531812 hasLocation W20245318124 @default.
• W2024531812 hasOpenAccess W2024531812 @default.

• next